Correlation Between Panion BF and Lotus Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Panion BF and Lotus Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Panion BF and Lotus Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Panion BF Biotech and Lotus Pharmaceutical Co, you can compare the effects of market volatilities on Panion BF and Lotus Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Panion BF with a short position of Lotus Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Panion BF and Lotus Pharmaceutical.

Diversification Opportunities for Panion BF and Lotus Pharmaceutical

0.44

Correlation Coefficient

Panion BF  Lotus Pharmaceutical

Very weak diversification

The 3 months correlation between Panion and Lotus is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Panion BF Biotech and Lotus Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lotus Pharmaceutical and Panion BF is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Panion BF Biotech are associated (or correlated) with Lotus Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lotus Pharmaceutical has no effect on the direction of Panion BF i.e., Panion BF and Lotus Pharmaceutical go up and down completely randomly.

Pair Corralation between Panion BF and Lotus Pharmaceutical

Assuming the 90 days trading horizon Panion BF Biotech is expected to under-perform the Lotus Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Panion BF Biotech is 1.29 times less risky than Lotus Pharmaceutical. The stock trades about -0.07 of its potential returns per unit of risk. The Lotus Pharmaceutical Co is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  31,150  in Lotus Pharmaceutical Co on September 30, 2024 and sell it today you would lose (4,000) from holding Lotus Pharmaceutical Co or give up 12.84% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Panion BF Biotech  vs.  Lotus Pharmaceutical Co

Panion BF Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Panion BF Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Lotus Pharmaceutical

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lotus Pharmaceutical Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Lotus Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Panion BF and Lotus Pharmaceutical

The main advantage of trading using opposite Panion BF and Lotus Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Panion BF position performs unexpectedly, Lotus Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lotus Pharmaceutical will offset losses from the drop in Lotus Pharmaceutical's long position.

The idea behind Panion BF Biotech and Lotus Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.